Our Services
We provide a comprehensive array of financial services to a diverse range of corporate clients, institutional investors, and high net worth investors.
Investment Banking
Equity Research
Capital Markets
Merchant Capital
Wealth Management
Prime Brokerage
Recent
Transactions
Over 140 financings and $6.8 Billion in aggregate as Lead, Joint, or Co-Manager in 2020
$11.7 Million
CMPO
// Sole Book-Running Manager
November 2021
M&A Sellside
Financial Advisor
// To Lowell Therapeutics
November 2021
$12.0 Million
Initial Public Offering
// Joint Book-Runner
November 2021
$90.1 Million
Registered Direct Offering
// Sole Placement Agent
November 2021
$26.0 Million
Initial Public Offering
// Sole Book-Running Manager
November 2021
$19.8 Million
Uplisting to Nasdaq
// Sole Placement Agent
November 2021
$1.0 Billion
Initial Public Offering
// Co-Manager
October 2021
$40.0 Million
Uplisting to Nasdaq
// Co-Bookrunner
October 2021
$175.0 Million
Initial Public Offering
// Co-Manager
October 2021
$100 Million
Initial Public Offering
// Co-Manager
October 2021
$9.5 Million
M&A (Sell-Side)
// Advisory
October 2021
![Maxim_Merchant-Capital_logo-01[1]](https://www.maximgrp.com/wp-content/uploads/2020/02/Maxim_Merchant-Capital_logo-011.svg "Maxim_Merchant-Capital_logo-01[1]"){kind=logo}
Merchant Capital
Maxim Merchant Capital’s skilled specialists have significant experience in raising private capital for both late-stage and early-stage private and public companies across a range of industries; predominantly in life sciences/biotechnology. Within the biotech sector, we look for companies that address significant unmet needs and have a clear regulatory path.
